Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.
Press releases published on June 18, 2025
Rosemark to Attend the 2025 Visiting Angels Annual Conference
EIN Presswire
·
June 18, 2025
Rosemark’s team will showcase the future of home care operations at this year’s conference in Boston, MA. MA, UNITED STATES, June 18, 2025 /EINPresswire.com/ -- The Rosemark team is heading to Boston to exhibit at the 𝟮𝟬𝟮𝟱 𝗩𝗶𝘀𝗶𝘁𝗶𝗻𝗴 𝗔𝗻𝗴𝗲𝗹𝘀 𝗔𝗻𝗻𝘂𝗮𝗹 …
Arcara Access Offers Local, Holistic Care for Menopause
EIN Presswire
·
June 18, 2025
Arcara Access’s Personalized Menopause Treatments provide holistic, whole-person care that treats the mind, body, and spirit. WESTBOROUGH, MA, UNITED STATES, June 18, 2025 /EINPresswire.com/ -- As menopause and perimenopause gain increasing national …
Liberty Partners Launches Bridgepoint Alliance in Partnership with CRR, LLP
EIN Presswire
·
June 18, 2025
Liberty Partners Launches Bridgepoint Alliance in Partnership with CRR, LLP to Support Growth of Lower-to-Middle Market CPA Firms BOSTON, MA, UNITED STATES, June 18, 2025 /EINPresswire.com/ -- Liberty Partners today announced the launch of Bridgepoint …
Agnisys Ignites DAC 2025 with IDesignSpec Suite v9, IDS-FPGA Launch, AI² and IDS-Integrate Enhancements.
EIN Presswire
·
June 18, 2025
Agnisys showcases next-generation EDA solutions at DAC 2025, including IDesignSpec Suite v9, IDS-FPGA Launch, AI² and IDS-Integrate Enhancements. BOSTON, MA, UNITED STATES, June 18, 2025 /EINPresswire.com/ -- Agnisys, the pioneer and industry leader in …
Rain Check, Please! Truly Hard Seltzer is Paying Fans with a “Rain Check” to Use on Their Next Pack If Fourth of July Plans Get Rained Out
GlobeNewswire
·
June 18, 2025
BOSTON, MA, June 18, 2025 (GLOBE NEWSWIRE) -- Summer weather can be unpredictable – and nothing puts a damper on a holiday weekend like a rained-out pool party. With recent rainfall trends tracking higher than usual1 and forecasts pointing to a wetter-than …
Progress Software CEO Yogesh Gupta Named an EY US Entrepreneur Of The Year® 2025 New England Award Winner
GlobeNewswire
·
June 18, 2025
Visionary CEO recognized for bold leadership, strategic growth, accelerated AI innovation and long-term stakeholder value creation BURLINGTON, Mass., June 18, 2025 (GLOBE NEWSWIRE) -- Progress Software (Nasdaq: PRGS), the trusted provider of AI-powered …
V2 Communications Receives Numerous Accolades at PR Club’s 57th Bell Ringer Awards, including the Inaugural Carillonneur Award
GlobeNewswire
·
June 18, 2025
BOSTON, June 18, 2025 (GLOBE NEWSWIRE) -- Integrated communications firm, V2 Communications (V2), was honored with eight awards at the PR Club’s 57th Bell Ringer Awards, including the inaugural Carillonneur Award, a new distinction recognizing a firm’s …
Tive CEO Krenar Komoni Named EY Entrepreneur Of The Year® 2025 New England Award Winner
GlobeNewswire
·
June 18, 2025
BOSTON, June 18, 2025 (GLOBE NEWSWIRE) -- Ernst …
Akari Therapeutics Bolsters Global IP Estate for its Novel Antibody Drug Conjugate (ADC) Immuno-Oncology Payload, PH1, with Recent Granting of Patent Protection Across India
GlobeNewswire
·
June 18, 2025
Differentiated PH1 payload is a spliceosome inhibitor designed to inhibit RNA splicing, leading to cancer cell death and activation of immune system through multiple mechanisms India represents a key territory with a rapidly growing incidence rate of …
Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia
GlobeNewswire
·
June 18, 2025
Global Phase 3 BRAVE study will evaluate the efficacy and safety of omaveloxolone in children 2 to <16 years old with Friedreich ataxia, a rare neurodegenerative disorder BRAVE study will explore the potential of omaveloxolone to address the critical unmet …
Eccogene Announces First Patient Dosed in Phase 1b Trial of AZD5004/ECC5004, a Novel Oral GLP-1 Receptor Agonist, in China
GlobeNewswire
·
June 18, 2025
BOSTON and SHANGHAI, June 18, 2025 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammatory conditions, today announced that the first …
Diagonal’s First-in-Class Clustering Antibody, DIAG723, Receives Orphan Drug Designation (ODD) from U.S. FDA and an ODD Positive Opinion from EMA for Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
GlobeNewswire
·
June 18, 2025
WATERTOWN, Mass., June 18, 2025 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company focused on correcting dysregulated signaling with clustering antibodies that address the underlying cause of intractable genetic diseases, today announced …
Fractyl Health Reinforces Intellectual Property Leadership in Metabolic Disease with Two New U.S. Patents Directed to Duodenal Resurfacing
GlobeNewswire
·
June 18, 2025
Robust intellectual property portfolio, built over more than a decade, designed to protect core innovations for treating metabolic diseases New U.S. patents strengthen Fractyl’s leadership in metabolic innovation by expanding its patent coverage of …
BPGbio Announces Presentation of Preliminary Clinical Data of Investigational BPM31510 for Primary CoQ10 Deficiency
GlobeNewswire
·
June 18, 2025
BPM31510 provides encouraging evidence of the potential for transformative benefit for a disease with high unmet need, supporting further development. The Company plans to seek guidance in Q3 2025 from the FDA regarding the development of BPM31510 for PCQD …